-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
LogicBio Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2021.
- LogicBio Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was -$833K, a 140% decline year-over-year.
- LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $3.24M, a 93.4% decline from 2020.
- LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $48.7M, a 384% increase from 2019.
- LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2019 was $10.1M, a 86.1% decline from 2018.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)